Cadila Healthcare gets nod for H1N1 vaccine; stock up 2%

Cadila Healthcare Ltd said on Wednesday it has received approval from the Drug Controller General of India to market the H1N1 vaccine in the country. The egg-based vaccine named 'VaxiFlu-S' will be marketed by Vaxxicare, a division of the company focusing on preventives, it said in a statement. Cadila Health has touched an intraday high of Rs 593.75 and an intraday low of Rs 574.00. At 11:18 hrs the share was quoting at Rs 586.00, up Rs 11.30, or 1.97%. It was trading with volumes of 17,899 shares, compared to its 5-day and 30-day average of 56,757 and 34,777 shares. Yesterday the share closed down 0.01% or Rs 0.05 at Rs 574.70. The company touched its 52 week high Rs 853.70 and 52 week low Rs 226.01 on 25 Mar, 2010 and 22 May, 2009, respectively. Currently, it is trading -31.36% below its 52-week high and 159.28% above its 52-week low. Market capitalisation stands at Rs 11,998.26 crore.